Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07017062

Clinical Evaluation of Hybrid Ceramic Occlusal Veneers Bonded With Two Self Adhesive Resin Cements

This randomized clinical trial aims to evaluate the clinical performance of hybrid ceramic occlusal veneers cemented with two different bonding protocols: a self-adhesive bonding protocol with adhesive enhancement (BeautiLink SA cement with BeautiBond Xtreme adhesive) versus another self-adhesive bonding protocol (RelyX U200 self-adhesive resin cement with 3M UNIVERSAL bond).

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Dentistry, Cairo University

Cairo, Egypt

Location status: Recruiting

Location contact

Faculty of Dentistry, Cairo University

CONTACT

00201002159535

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Age ≥ 21 years
  • Vital teeth
  • Sufficient tooth structure for veneer retention
  • Willing and able to provide written informed consent
  • Ability to attend all follow-up appointments
  • Adequate oral hygiene as determined by the investigator

Exclusion criteria

  • • Patients with active periodontal disease (probing depth > 4mm, bleeding on probing)
  • Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination)
  • Poor oral hygiene (plaque index > 30%)
  • Pregnancy or nursing
  • Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression)
  • Known allergies to study materials (ceramic, or resin cement components)
  • Inability to comply with study requirements
  • Current participation in other dental clinical trials
  • Active orthodontic treatment

Treatment and study plan

hybrid ceramic occlusal veneers

Other

occlusal veneers cemented with self adhesive resin cements

Primary outcomes

  1. Marginal discoloration

    Time frame: 18 months

    Measuring device: Modified USPHS criteria Alpha: No discoloration on margin Bravo: Discoloration found at margin Charlie: Discoloration with penetration in a pulpal direction

Secondary outcomes

  1. Retention

    Time frame: 18 months

    Measuring device: Modified USPHS criteria Alpha: retained Charlie: debonded

  2. Marginal adaptation

    Time frame: 18 months

    Measuring device: Modified USPHS criteria Alpha: explorer does not catch or has one way catch when drawn across restoration/tooth interface Bravo: explorer falls into crevice when drawn across the restoration tooth interface Charlie: Dentin or base exposed along margin

  3. Postoperative hypersensitivity

    Time frame: 18 months

    Measuring device: Modified USPHS criteria Alpha: Absent Charlie: Present

  4. Recurrent caries

    Time frame: 18 months

    Measuring device: Modified USPHS criteria Alpha: no evidence of caries at the margin of restoration Charlie: evidence of caries continuous with the margin of restoration

Study contacts

Contact information is provided by the study sponsor or research team.

Hayat Ibrahim El Banna, Lecturer

CONTACT

[email protected]

00201001248734

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Clinical Evaluation of Hybrid Ceramic Occlusal Veneers Bonded With Two Self Adhesive Resin Cements A Randomized Clinical Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2027
First posted
Jun 12, 2025
Registry last updated
Jun 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.